Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Dronedarone (Multaq) in AF Research
2026-09-22
Build exposure-matched atrial fibrillation workflows with Dronedarone (Multaq), from solvent preparation to automated whole-cell patch clamp. The approach distinguishes broad antiarrhythmic pharmacology from clinically relevant KCa2-channel activity, helping researchers avoid false mechanistic conclusions.
-
Malate as a Flux Control in Tumor Immunometabolism
2026-09-22
Malate is more than a tricarboxylic acid cycle intermediate: it is a practical control for studying mitochondrial redox, metabolic flux, and immune consequences. This article explains how to use malate to interpret PDHA1-linked findings in cholangiocarcinoma without confusing a metabolic probe with a direct immune target.
-
Cinoxacin: A UTI Research Assay Framework
2026-09-21
Cinoxacin is a quinolone antibiotic with a distinctive value in urinary tract infection research: it can connect concentration–response testing with clinically meaningful exposure and infection endpoints. This article develops a rigorous assay framework grounded in product specifications and insights from a phase 3 immunology trial.
-
Brefeldin A (BFA): Reliable Cell Assays
2026-09-21
A scenario-driven guide to using Brefeldin A (SKU B1400) in viability, proliferation, cytotoxicity, trafficking, and ER-stress workflows. It explains dose selection, solvent and storage controls, assay compatibility, data interpretation, and practical criteria for selecting a dependable research reagent.
-
DHHC9–STRN4 Palmitoylation Drives YAP Metastasis
2026-09-20
The reference study identifies a DHHC9–STRN4 palmitoylation mechanism that activates YAP and promotes adenocarcinoma cell migration and metastasis. Its combination of genetic, proteomic, functional, and pharmacological evidence positions DHHC9 as a candidate therapeutic target while highlighting the need for stronger selectivity and translational validation.
-
Cyclic Pifithrin-α Hydrobromide Assay Design
2026-09-19
Cyclic Pifithrin-α hydrobromide is a p53 inhibitor for dissecting stress-induced apoptosis, growth arrest, and DNA-damage signaling. This guide connects its established pharmacology with the CGRP/SP–Piezo2 neuroinflammatory axis while defining practical controls and translational limits.
-
4-Hydroxytamoxifen: Practical Protocol and QC Guide
2026-09-18
4-Hydroxytamoxifen (SKU B6167) provides a DMSO-compatible estrogen receptor modulator for controlled in vitro workflows, including breast cancer research, prostate cancer research, apoptosis assays, and cardiac myocyte calcium handling studies. It should not be selected for protocols requiring water- or ethanol-based solubilization, and long-term storage of prepared solutions should be avoided.
-
Alfuzosin HCl: Gastroretentive Research Workflows
2026-09-18
Build reproducible Alfuzosin HCl assays around receptor pharmacology, smooth-muscle models, and gastroretentive formulation testing. This guide translates a peer-reviewed sponge-delivery study into practical preparation, release-testing, imaging, and troubleshooting workflows for benign prostatic hyperplasia research.
-
PQQ–Nrf2–IGF1R Axis in Age-Related Osteoarthritis
2026-09-17
This reference study identifies a PQQ–Nrf2–IGF1R pathway that links antioxidant defense to cartilage matrix maintenance in age-related osteoarthritis. Its combination of long-term mouse intervention, inflammatory chondrocyte models, tissue analysis, and loss-of-function experiments provides a mechanistic framework for studying oxidative stress and senescence in joint degeneration.
-
Dexamethasone as an Anti-Inflammatory Assay Benchmark
2026-09-17
Dexamethasone is a glucocorticoid anti-inflammatory research tool for dissecting NF-κB activity, cell differentiation, autophagy, and neuroinflammation. This article translates a rosemary-root discovery study into a rigorous framework for selecting controls, endpoints, and interpretation strategies.
-
Moesin as a Biomarker of Endothelial Injury in Sepsis
2026-09-16
The reference study identifies serum moesin (MSN) as a candidate biomarker of endothelial injury and sepsis severity, linking elevated MSN with SOFA scores, procalcitonin, and experimental lung damage. Its combination of patient data, mouse sepsis models, and endothelial-cell mechanistic experiments supports a role for MSN in ROCK1/MLC- and NF-κB-associated barrier dysfunction, while also defining important limits for clinical translation.
-
T. pallidum, Mitochondrial ROS, and Hepatocyte Apoptosis
2026-09-15
The reference study identifies a mitochondria-centered mechanism by which Treponema pallidum promotes hepatocyte apoptosis: mitochondrial ROS accumulation is associated with cardiolipin peroxidation, mitochondrial dysfunction, and activation of the intrinsic apoptotic cascade. Its integrated measurements provide a useful framework for investigating infection-associated liver injury and for separating mitochondrial permeability changes from downstream cell-death signaling.
-
Griseofulvin: A Mechanism-First Assay Guide
2026-09-15
Griseofulvin is a microtubule associated inhibitor whose antifungal value depends on separating true mitotic disruption from nonspecific toxicity. This mechanism-first guide connects fungal assays with a validated aneugenic mechanism framework while defining practical limits for cross-domain interpretation.
-
Anti-Inflammatory and Anti-Angiogenic Airway Stents
2026-09-14
Zhao et al. developed PAGL, an electrospun airway stent combining anlotinib hydrochloride with silver nanoparticles to address infection, inflammation, angiogenesis, and fibroblast activation in tracheal in-stent restenosis. In vitro, rabbit, and RNA-sequencing results support a locally acting, multi-mechanism strategy, while translational limitations remain around long-term safety, dosing, and human validation.
-
AAL-993: From VEGFR Biology to Translational Insight
2026-09-14
A mechanistic and strategic guide to using AAL-993 as a selective VEGF receptor inhibitor in tumor angiogenesis research, with practical considerations for assay design, model selection, and translational interpretation.